The company
Ecolab Inc.
ECL · NYSE
ECL stood above a rising 150-day average in 22 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 5.5% above that average now. Chemicals: 25% of its 85 stocks in an uptrend (−1 points in four weeks); Materials: 18% (−6 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 5
- Industry in uptrend
- 25% -1 in 4 wk
- Insider buys, 12 months
- $7.7M
- Insider sales, 12 months
- $48.2M
- Officials’ trades on record
- 114
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 22 of 52 weeks.
Chemicals: A minority of its stocks are in an uptrend and the share has held steady. Materials: Few of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
114 disclosed lines: House 92, Senate 5, executive 17; 23 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 31 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 24 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $100k–$250k | 18 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 3 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 22 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 20 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $100k–$250k | 19 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 18 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 18 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 18 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 15 May 2026filed 1 Jul 2026 |
| John Boozman Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 15 May 2026filed 16 Jun 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Eric Mark GreenDirector | bought | 3,370at $276.58 | 11 Sep 2026filed 14 Sep 2026 |
| Eric Mark GreenDirector | bought | 320at $277.29 | 11 Sep 2026filed 14 Sep 2026 |
| Christophe BeckCHAIRMAN, PRESIDENT & CEO | sold | 17,862at $280.14 | 18 Aug 2026filed 20 Aug 2026 |
| Gregory B. CookCo-COO - Global Businesses | sold | 4,567.424at $285.13 | 11 Aug 2026filed 11 Aug 2026 |
| Scott D. KirklandCHIEF FINANCIAL OFFICER | sold | 3,357at $276.96 | 30 Jul 2026filed 31 Jul 2026 |
| Benjamin M. ClarkEVP - Global Supply Chain | bought | 1,000at $263.83 | 11 Jun 2026filed 15 Jun 2026 |
| Michel D. DoukerisDirector | bought | 7,750at $258.00 | 10 Jun 2026filed 11 Jun 2026 |
| Darrell R. BrownCo-COO - Global Markets | sold | 10,000at $260.89 | 9 Jun 2026filed 10 Jun 2026 |
| Suzanne M. VautrinotDirector | sold | 1,004at $264.98 | 27 May 2026filed 27 May 2026 |
| David MaclennanDirector | bought | 1,000at $250.65 | 13 May 2026filed 14 May 2026 |
| David MaclennanDirector | bought | 800at $256.91 | 4 May 2026filed 5 May 2026 |
| Gregory B. CookEVP & PRES - INST GROUP | sold | 3,519at $304.25 | 26 Feb 2026filed 27 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.